Smoking Cessation Aids and Strategies: Insights from Norway's Population

Nov.07.2022
Smoking Cessation Aids and Strategies: Insights from Norway's Population
Study finds smokers in Norway prefer e-cigarettes and snus as aids to quitting and non-users rarely use other aids.

According to a study titled "Smoking Cessation Aids and Strategies: A Population Survey of Former and Current Smokers in Norway," smokers tend to choose from various smoking cessation aids and strategies during their quitting process.


Smoking rates in Norway have decreased from 30% in 2001 to 12% in 2018. Tobacco consumption in the country is divided into combustible products (cigarettes) and non-combustible products (oral tobacco).


The research team conducted a cross-sectional study in Norway in 2017, 2018, 2019 and 2020. The analyzed sample consisted of adult smokers who were grouped according to the number of times they attempted to quit smoking.


A study has shown that among daily smokers, 56% reported using smoking cessation aids, with electronic cigarettes and nicotine mouth sprays being the most popular types. Interestingly, smokers who use nicotine mouth sprays are less likely to use other nicotine replacement therapies. In fact, using mouth sprays and having a support system through online communities and mobile apps are associated with increased success in quitting smoking, while using NRT is linked to failed attempts to quit. When looking at individual aids and combined use of aids, only nicotine mouth sprays were found to be directly linked to successful smoking cessation.


Researchers also found that smokers who use Snus often do not use other smoking cessation aids. "It was discovered that using Snus is an "independent" smoking cessation aid, with only weak associations with the use of other aids. Further investigation is needed into preferences for smoking cessation aids, especially among smokers who have little or no access to healthcare and/or find traditional cessation aids unappealing.


Statement:


This article is compiled from third-party information sources and is intended for industry communication and learning purposes only.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the article's content. The article's translation is intended solely for industry communication and research.


Due to the limitations of the compiler's abilities, the translated article may not fully convey the same meaning as the original. Therefore, please refer to the original text for accuracy.


2FIRSTS maintains full alignment with the Chinese government regarding any domestic or international issues involving Hong Kong, Macau, Taiwan, and foreign relations.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

UK's First Week of Disposable E - cigarette Ban: Convenience Stores Suffer £5m Loss, Illegal Sales Still Exist
UK's First Week of Disposable E - cigarette Ban: Convenience Stores Suffer £5m Loss, Illegal Sales Still Exist
Disposable e-cigarette ban causes £5 million sales loss in UK convenience stores in first week, illegal sales continue.
Jun.23 by 2FIRSTS.ai
FDA Appoints Bret Koplow as Acting Director of CTP
FDA Appoints Bret Koplow as Acting Director of CTP
According to the U.S. Food and Drug Administration’s website, Bret Koplow has been appointed acting director of the Center for Tobacco Products (CTP). Koplow has been with the FDA since 2011, holding several key roles, most recently serving as senior advisor to the FDA Commissioner.
May.21 by 2FIRSTS.ai
U.S. Texas Governor Signs E-Cigarette Bill: Bans Vapes Made by China and "Foreign Adversaries"
U.S. Texas Governor Signs E-Cigarette Bill: Bans Vapes Made by China and "Foreign Adversaries"
Texas Governor Greg Abbott signed SB 2024, effective September 1, 2025, tightening e-cigarette regulations. The law targets marketing to minors, vape products disguised as everyday items, illegal additives, and e-cigarettes made by "foreign adversaries" like China.
Jun.24 by 2FIRSTS.ai
State Tobacco Monopoly Administration Meets with Representatives from British American Tobacco
State Tobacco Monopoly Administration Meets with Representatives from British American Tobacco
On May 26, Wang Gongcheng, Member of the Party Leadership Group and Deputy Director of the State Tobacco Monopoly Administration, met in Beijing with BAT Management Board Member and Regional Director for Asia-Pacific, Middle East & Africa, Zhanoski. The two sides held friendly talks.
May.27 by 2FIRSTS.ai
Scotland in the UK to Regulate Nicotine Pouches Under New Tobacco Control Measures
Scotland in the UK to Regulate Nicotine Pouches Under New Tobacco Control Measures
The Scottish government in the UK plans to include nicotine pouches, commonly known as “snus,” in its tobacco control legislation, supporting the expansion of regulation to new types of tobacco products, including heated tobacco and “snus.”
May.07 by 2FIRSTS.ai
Philip Morris Challenges Disposable Vape Ban in Swiss Canton, Federal Court to Deliver Key Ruling
Philip Morris Challenges Disposable Vape Ban in Swiss Canton, Federal Court to Deliver Key Ruling
PMI challenges Swiss canton's puff ban in court, citing federal law violations and harm to adult smokers. The case could redefine health policy authority in Switzerland, amid growing national restrictions.
Jun.27 by 2FIRSTS.ai